The Robotic General Surgery Market is expected to register a CAGR of 14.2% from 2024 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Type (Coronary stents, Peripheral stents, EVAR stent grafts). The report further presents analysis based on the End User (Hospitals, Cardiac centers, Ambulatory surgical centers). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the Report
The report Robotic General Surgery Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Robotic General Surgery Market Segmentation
Type
- Coronary stents
- Peripheral stents
- EVAR stent grafts
Type
- Coronary stents
- Peripheral stents
- EVAR stent grafts
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Robotic General Surgery Market Growth Drivers
- Surging Surgical Procedures: The number of surgeries performed across the globe is growing owing to the surge in the geriatric population and the rise in the prevalence rate of chronic diseases. As per the American College of Rheumatology, every year, ~790,000 total knee replacements and 544,000 hip replacements are performed in the US; the figure is expected to grow with the rise in the geriatric population in the country. Thus, the growing number of surgeries drives the market for robotic general surgeries.
- Growing Prevalence of Chronic Diseases: In the last 25 years, the incidence of chronic diseases has increased worldwide owing to lifestyle changes, which result in an increase in the number of surgeries. According to the 2021 National Health Statistics Reports from the Centers for Disease Control and Prevention, the incidence of obesity has reached 41.9% among adults and 19.7% among children and adolescents aged 2: 19 years old. Robotic surgery for obesity has advantages over conventional surgery owing to its 3D vision and precise, intuitive multi-range instruments that add more safety to the patients. Thus, the rise in the prevalence of chronic conditions fuels the robotic general surgeries market growth.
- Technological Advancements: In the case of robotic general surgery, technological advancement has revolutionized procedures for surgeons in many ways. This is due to the fact that the robotic arms provide the surgeon with improved dexterity and precision as opposed to manual instruments, hence enabling small incisions during the performance of minimally invasive surgeries. Advanced training simulators, based on virtual reality, enable the development of the surgeon's skills in a risk-free environment.
Robotic General Surgery Market Future Trends
- Incorporation of AI-Based Features in Surgical Robots: The integration of artificial intelligence in surgical robots helps provide real-time analysis, decision support, and predictive analysis. During surgeries, such robots can reduce human errors, identify critical areas, and optimize surgical planning. For instance, in May 2023, Smith+Nephew, the global medical technology company, introduced two key products for its robotics and digital surgery portfolio—Personalized Planning powered by AI and RI.INSIGHTS Data Visualization Platform. Advanced AI analytics platform integrated with the CORI Surgical System will offer personalization when performing joint replacement procedures.
- Investment in Robotics: Health care robotics investment sharply transforms the industry at all levels. There is huge demand for advanced health care robotic-assisted surgeries, with many investments in the systems to advocate precision, rapid recovery times, and better patient results. Increased funding from both the government and private sectors enhances advanced healthcare robotics, thus stimulating growth and innovation.
- Teleoperated Surgeries: Teleoperated surgeries represent a great leap in the profession of surgical practice. Teleoperated surgeries permit surgeons to carry out procedures from a distance, hence making specialized care accessible in areas that are less served or are actually rural. Improvements in robotics, high-speed internet and secure data transmission improve the feasibility and safety of teleoperated procedures. In this regard, teleoperated surgeries may help reduce the expenses involved for travel on the part of patients for specialized care by saving both healthcare providers and patients expense.
Robotic General Surgery Market Opportunities
- Growing Number of Product Approvals and Launches: Product approvals accelerate the emergence of new technology in the market. In March 2024, Intuitive Surgical, Inc., a global pioneer of robotic: assisted surgery, received the US Food and Drug Administration (FDA) 510(k) clearance for da Vinci 5—the company’s next: generation multiport robotic system. Da Vinci 5’s design includes over 150 engineering enhancements.
- Increasing Minimally Invasive Surgeries: Patients are turning to MIS as it brings many advantages like tiny incisions, minimal pain, shorter periods of recovery, and minimal scarring. Sophisticated systems of robotics have now advanced even more whereby surgeons are also made extremely sensitive in the way of making and controlling movements with the precision they deliver during a procedure. In this context, healthcare has taken a novel twist in its approach with the introduction of robots in minimally invasive surgical procedures.
- Training and Education: Programs for robotic general surgery training and education should feature surgeons fully competent and ready to use the robotic systems in surgery. Many embrace virtual reality and simulation labs to practice techniques on harmless test subjects before applying them to actual patients. Their main aim is to build a culture of proficiency, improved surgical outcomes, and patient safety in general robotic surgery.
Robotic General Surgery Market Regional Insights
The regional trends and factors influencing the Robotic General Surgery Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Robotic General Surgery Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
- Get the Regional Specific Data for Robotic General Surgery Market
Robotic General Surgery Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2024 | US$ XX million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2025 - 2031) | 14.2% |
Historical Data | 2021-2023 |
Forecast period | 2025-2031 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Robotic General Surgery Market Players Density: Understanding Its Impact on Business Dynamics
The Robotic General Surgery Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Robotic General Surgery Market are:
- Zimmer Biomet Robotics (Medtech SA)
- Smith and Nephew plc
- Stryker Corporation
- Mazor Robotics
- THINK Surgical, Inc.
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Robotic General Surgery Market top key players overview
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Robotic General Surgery Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Robotic General Surgery Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Artificial Intelligence in Defense Market
- Queue Management System Market
- Arterial Blood Gas Kits Market
- Enzymatic DNA Synthesis Market
- Greens Powder Market
- Travel Vaccines Market
- Artificial Turf Market
- Space Situational Awareness (SSA) Market
- Nurse Call Systems Market
- Small Molecule Drug Discovery Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Players operating in the market are SSI Innovations, Meril Life Sciences, Siemens Healthineers, Smith and Nephew, Stryker, Medtronic Plc, CMR Surgical, and Renishaw Plc
Hospitals segment, by end user, dominated the market in 2023.
The Robotic General Surgery Market is estimated to witness a CAGR of 14.2% from 202#to 2031
North America region dominated the robotic general surgery market in 2023.
Growing Number of Product Approvals and Launches act as a opportunity for growth of the market in forecast period.
The major factors driving the robotic general surgery market are:
1. Surging Surgical Procedures.
2.Growing Prevalence of Chronic Diseases
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. Zimmer Biomet Robotics (Medtech SA)
2. Smith and Nephew plc
3. Stryker Corporation
4. Mazor Robotics
5. THINK Surgical, Inc.
6. Hansen Medical, Inc.
7. Renishaw plc.
8. Intuitive Surgical, Inc.
9. KUKA AG
10. TransEnterix Surgical, Inc.